Drug Interaction study between AZD3480 and warfarin - DDI

Study identifier:D3690C00014

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A single-centre, double blind, randomized, two-way cross-over study of repeated doses of AZD3480 and single dose of warfarin to evaluate the pharmacokinetic interaction of AZD3480 and warfarin and the effect of AZD3480 pharmacodynamic in healthy male subjects (phase I

Medical condition

Alzheimer's disease

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD3480, Placebo, Warfarin

Sex

Male

Actual Enrollment

26

Study type

Interventional

Age

18 Years - 45 Years

Date

Study Start Date: 01 Sept 2007
Primary Completion Date: 01 Feb 2009
Study Completion Date: 01 Feb 2009

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Jul 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria